Anti-synthetases t-RNA and anti-nucleolar antibodies;Anticuerpos antisintetasas ARNt y antinucleolares

Revista Espanola de Reumatologia

Volumn 23, Issue 9, 1996, Pages 384-388

  López Longo, Francisco Javier ^a   Grau, Raquel ^a   Moreno, Alonso Carlos ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; NUCLEOLUS ANTIBODY; RNA ANTIBODY; TRANSFER RNA; UNCLASSIFIED DRUG;

AUTOIMMUNITY; DIAGNOSIS; HUMAN; POLYMYOSITIS; PSYCHOSIS; REVIEW;

EID: 0030472515     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Reichlin M. Mattioli M Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol 1976; 5 12-20
2. .Nishikai M, Reichlin M. Purification and characterization of a nuclear non-histone basic protein (Mi-1) which reacts with anti-immunoglobulin sera and the sera of patients with dermatomyositis Mol Immunol 1980, 17 1-129-1 141
3. Targoff IN, Reichlin M The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28. 796-803-
4. Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 1977, 59 176-178.
5. Nishikai M, Reichlin M Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23 881-888.
6. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase. A model for autoimmunity. Nature (Lond) 1983, 304: 177-179.
7. Mathews MB, Reichlin M, Hughes GRV, Bernstein RM Antithreonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984; 160: 420-434
8. Okada N, Mukai R, Harada F et al. Isolation of a novel antibody, which prepitates ribonucleoprotein complex containing threonine tRNA from a patient with polymyositis. Eur J Biochem 1984; 139: 425-429
9. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA Ala coexist and are associated with myositis. J Exp Med 1986: 163: 1 281-1 291
10. Targoff IN, Arnett FC, Reichlin M Antibody to threonyl transfer RNA synthetase in myositis sera Arthritis Rheum 1988; 31: 515-524.
11. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 1990; 144 1.7371.743.
12. Targoff IN. Arnett FC. Clinical manifestations in patients with antibodies to PL-12 antigen (alanyl-t-RNA synthetase). Am J Med 1990; 88 241-251
13. Yang DCH, Dang CV, Arnett FC. Rat liver histidyl-t-RNA synthetase Purification and inhibition by the myositis-specific anti-Jo 1 autoantibody Biochem Biophys Res Commun 1984; 120. 15-21.
14. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
15. Martin A, Shulman MJ, Tsui FW. Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J 1995; 9: 1.226-1.233.
16. Miller FW, Twitty SA, Biswas T. Plotz PH. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of antijo 1 autoantibodies J Clin Invest 1990: 85: 468-475.
17. Targoff IN, Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987, 138: 2.874-2.882.
18. Yoshida S, Akizuki M, Mimon T. Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26: 604-611.
19. Hirakata M, Mimon T, Akizuki M, Craft J. Hardin JA. Homma M Autoantibodies to small nuclear and cytoplasrmc ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35: 449-456.
20. Vázquez-Abad D, Rothfield N. Sensitivity and specificity of anti-Jo 1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 1996. 39. 292-296
21. Oddis CV, Medsger TA, Cooperstein LA A subluxing arthropathy associated with the anti-Jo 1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 1990. 33 1.640-1 645.
22. De Rooij DJ, Van de Putte LB, Habets Wj, Verbeek AL, Van Venrooij WJ The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens Scand J Rheumatol 1988, 17: 353-364.
23. Bernstein RM, Morgan SH, Chapman J et at. Anti-Jo 1 antibody: a marker for myositis with interstitial lung disease. Br Med J 1984, 289: 151-152.
24. Kazmers IS, Scovili CD, Schumacher HR. Polymyositis associated with apatite arthritis J Rheumatol 1988; 15. 1.0191.021.
25. Reimer G, Scheer V, Peters JM, Tan EM. Immunolocalization and partial characterization of a nucleolar autoantigen (PMScl) associated with polymyositis/.scleroderma overlap syndromes J Immunol 1986; 137 3.802-3 808
26. Reimer G, Pollard KM, Penning CA. Monoclonal autoantibodiea and some human scleroderma sera target a 34 KDa nucleolar protein of U3-ribonucleoprotein particle. Arthritis Rheum 1987; 30: 793-800
27. Reimer G, Rose KM, Scheer U et al Autoantibody to RNA polymerase I in scleroderma sera J Clin Invest 1987, 79: 6572
28. Alderuccio F, Chan EKL, Tan EM. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75 KD acidic protein of the nucleolar complex. J Exp Med 1991; 173: 941-952.
29. Gelpi C, Alguero A, Martinez MA, Vidai S, Juarez C. Rodriguez-Sanchez JL Identification of protein components reactive with anti-PM-Scl autoantibodies. Clin Exp Immunol 1990; 81 59-64
30. Elkon K, Skelly S, Parnassa A et al Identification and chemical synthesis of a ribosomal protein antigemc determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1986; 83: 7.419-7.423.
31. Reddy R, Tan EM, Henning D, Nogha K, Busch H Detection of a nucleolar 7-2 ribonucleoprotein and cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma J Biol Chem 1983; 258: 1.383-1.386.
32. Rodriguez-Sánchez JL, Gelpi C, Juárez C et al. Anti-NOR-90: a new autoantibody in scleroderma that recognizes a 90 KDa component of the nucleolus organizing region of chromatin. J Immunol 1987; 139. 2.579-2.584.
33. Scheer U, Rose KM. Localization of RNA polymerase I in interphase cells and mitotic chromosomes by light and electron microscopic immunocytochemistry. Proc Natl Acad Sci USA 1984. 81: 1.431-1.435.
34. Pfeiffe J, Anderer FA, Franke M. Characterization of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis 1986; 45: 978-986.
35. Reimer G, Steen VP, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma) Arthritis Rheum 1988. 31: 525-532.
36. Reveille JD, Arnett FC Frequencies of scleroderma-related autoantibodies in patients meeting the ACR criteria for systemic sclerosis: reply [carta]. Arthritis Rheum 1993, 36. 1 3331.334
37. Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum 1992, 35: 1.211-1 217.
38. Kuwana M, Okano Y, Kaburaki J. Tojo T, Medsger TA. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies Arthritis Rheum 1994; 37: 902-906.
39. Kuwana M. Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994. 37. 75-83.
40. Satoh M. Kuwana M. Ogasawara T et al. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. J Immunol 1994; 153 5 838-5.848.
41. Satoh M. Ajmani AK. Ogasawara T et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome Specific recognition of the phosphorylated (IIO) form by a subset of human sera J Clin Invest 1994; 94: 1.981-1.989
42. Miyachi K, Tan EM. Antibodies reacting with ribosomal ribonucleoproteins in connective tissue disease Arthritis Rheum 1979; 22. 87-93
43. Corres JM. Rodríguez C. Zea AC. Segui J. Sanchidrian I Anticuerpos antiribosomales en lupus eritematoso sistémico. Rev Clin Esp 1995. 195: 16-21.
44. Bonfa E, Golombek SJ. Kaufman LD et al Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265-271.
45. Nojima V, Minota S, Yamada A, Takaku F. Aotsuka S. Yokohari R Correlation of antibodies to ribosomal P protein with pyschosis in patients with systemic Iupus erythematosus. Ann Rheum Dis 1992, 51: 1 053-1 055.
46. Teh LS. Bedwell AE, Isenberg DA et al Antibodies to protein P in systemic lupus erythematosus Ann Rheum Dis 1992. 51: 489-494
47. Sato T, Uchiumi T. Ozawa T et al. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease J Rheumatol 1991; 18 1 681-1.684.
48. Van Dam A, Nossent H, De Jong J et al Diagnostic value of antibodies against ribosomal phosphoproteins: a cross sectional and longitudinal study. J Rheuniatol 1991: 18 1.0261.034.